{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:19:24Z","timestamp":1789705164598,"version":"4.0.1"},"reference-count":24,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Acinetobacter species are major pathogens responsible for hospital-acquired infections. This study aimed to compare the clinical characteristics, outcomes, and antimicrobial resistance between Acinetobacter baumannii (AB) and non-baumannii Acinetobacter (NBA) species. In this retrospective cohort study, we analyzed data from adult patients (aged 18 or older) with Acinetobacter bacteremia treated at two tertiary hospitals from July 2020 to November 2023. Among 260 cases of Acinetobacter bacteremia, 42 (16.2%) involved NBA species. The AB group exhibited higher antimicrobial resistance rates across all tested agents, except for minocycline. Female patients, younger patients, and those with catheter-related infections were more commonly observed in the NBA group than in the AB group, while pneumonia and septic shock were more prevalent in the AB group. In a multivariable analysis of 30-day mortality, factors associated with higher mortality included moderate to severe liver disease, chronic kidney disease, carbapenem resistance, septic shock, and higher Pitt Bacteremia Scores. When stratified by carbapenem resistance (CR) status, only CR-AB exhibited significantly lower 30-day survival rate (33.4%) compared to that of the other groups (non-CR-NBA, 77.3%; CR-NBA, 77.8%; non-CR-AB, 90.1%; p &lt; 0.001). Our findings highlight distinct clinical differences between AB and NBA bacteremia cases; however, the mortality rate for non-CR-AB was comparable to that observed in NBA bacteremia.<\/jats:p>","DOI":"10.3390\/pathogens14010046","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:30:45Z","timestamp":1736328645000},"page":"46","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Analysis of Clinical Characteristics and Antimicrobial Resistance Between Acinetobacter baumannii and Other Acinetobacter Species"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-8940","authenticated-orcid":false,"given":"Si-Ho","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-6734","authenticated-orcid":false,"given":"Seok Jun","family":"Mun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan 47392, Republic of Korea"},{"name":"Paik Institute for Clinical Research, Inje University College of Medicine, Busan 47392, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and Pathophysiological Overview of Acinetobacter Infections: A Century of Challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jinf.2011.12.008","article-title":"Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States","volume":"64","author":"Wisplinghoff","year":"2012","journal-title":"J. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.02992-14","article-title":"Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii","volume":"58","author":"Chusri","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kang, H.M., Kim, K.R., Kim, G., Lee, D.-g., Kim, Y.J., Choi, E.H., Lee, J., and Yun, K.W. (2024). Antimicrobial resistance genes harbored in invasive Acinetobacter calcoaceticus-baumannii complex isolated from Korean children during the pre-COVID-19 pandemic periods, 2015\u20132020. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1410997"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.resmic.2011.02.006","article-title":"Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus\u2013Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)","volume":"162","author":"Nemec","year":"2011","journal-title":"Res. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s100960000315","article-title":"Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii","volume":"19","author":"Ku","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jmii.2019.09.007","article-title":"The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains","volume":"52","author":"Koizumi","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s13361-018-1911-4","article-title":"Insight into Identification of Acinetobacter Species by Matrix-Assisted Laser Desorption\/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) in the Clinical Laboratory","volume":"29","author":"Li","year":"2018","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1469-0691.2011.03696.x","article-title":"Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS","volume":"18","author":"Espinal","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1341-321X(06)70898-4","article-title":"Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: Comparison with A. baumannii bacteremia","volume":"12","author":"Choi","year":"2006","journal-title":"J. Infect. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_13","unstructured":"(2024, November 05). CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, Available online: https:\/\/www.cdc.gov\/infection-control\/media\/pdfs\/Guideline-BSI-H.pdf."},{"key":"ref_14","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2023). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement: CLSI Document M100, Clinical and Laboratory Standards Institute. [33rd ed.]."},{"key":"ref_15","first-page":"722","article-title":"Studies on bacterial taxonomy. X. The revision of species under Acromobacter group","volume":"86","author":"Brisou","year":"1954","journal-title":"Ann. Inst. Pasteur."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/jb.95.5.1520-1541.1968","article-title":"A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter)","volume":"95","author":"Baumann","year":"1968","journal-title":"J. Bacteriol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1099\/00207713-36-2-228","article-title":"Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter baumannii sp. nov. Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and Emended Descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii","volume":"36","author":"Bouvet","year":"1986","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/AAC.01533-08","article-title":"Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics","volume":"53","author":"Jara","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Al Atrouni, A., Joly-Guillou, M.-L., Hamze, M., and Kempf, M. (2016). Reservoirs of Non-baumannii Acinetobacter Species. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00049"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1469-0691.2005.01093.x","article-title":"Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals","volume":"11","author":"Dijkshoorn","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","unstructured":"(2023). Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data, European Centre for Disease Prevention and Control and World Health Organization."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kim, D., Yoon, E.-J., Hong, J.S., Choi, M.H., Kim, H.S., Kim, Y.R., Kim, Y.A., Uh, Y., Shin, K.S., and Shin, J.H. (2022). Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017\u20132019: Phase I Report From Kor-GLASS. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.799084"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijantimicag.2011.08.006","article-title":"Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea","volume":"39","author":"Park","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jmii.2024.01.008","article-title":"A 19-year longitudinal study to characterize carbapenem-nonsusceptible Acinetobacter isolated from patients with bloodstream infections and the contribution of conjugative plasmids to carbapenem resistance and virulence","volume":"57","author":"Chen","year":"2024","journal-title":"J. Microbiol. Immunol. Infect."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/1\/46\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:25:06Z","timestamp":1759919106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/1\/46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["pathogens14010046"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14010046","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]}}}